Company

NOVELION THERAPEUTICS INC. (0000827809)

Standardized SEC financial data for NOVELION THERAPEUTICS INC. — income statement, balance sheet, cash flow and 40+ ratios, available as a clean JSON API. CIK 0000827809 · Pharmaceutical Preparations.

Gross margin

54.2%

Operating margin

-38.4%

Net margin

-83.0%

Revenue growth (YoY)

-5.8%

Return on equity

121.9%

Free cash flow

-$55.9M

Current ratio

0.25×

Ratios for fiscal year 2018, standardized from SEC filings.

Income statement

USD	FY2016	FY2017	FY2018
Revenue	$13.6M	$138.4M	$130.4M
Cost of revenue	$6.0M	$77.2M	$59.7M
Gross profit	$7.6M	$61.2M	$70.7M
R&D expense	$14.8M	$49.0M	$38.8M
SG&A expense	$29.5M	$96.5M

Balance sheet

USD	FY2016	FY2016	FY2016	FY2017	FY2018
Cash & equivalents	—	—	$108.9M	$55.4M	$45.2M
Inventory	—	—	$15.7M	$15.9M	$12.7M
Total current assets	—	—	$166.1M	$104.9M	$102.5M
Property, plant & equipment

Cash flow

USD	FY2016	FY2017	FY2018
Operating cash flow	-$34.4M	-$54.9M	-$55.5M
Capital expenditures	$155K	$754K	$442K
Free cash flow	-$34.5M	-$55.7M	-$55.9M
Investing cash flow	$25.3M	-$754K	-$442K
Financing cash flow	-$23.5M	$109K

Get 0000827809 data via API

# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/0000827809/financials \
  -H "X-API-Key: YOUR_KEY"

# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/0000827809/income-statement?format=csv" \
  -H "X-API-Key: YOUR_KEY"

Get a free API key Use with Claude (MCP) →View 0000827809 filings on SEC EDGAR →